The road to hell is paved with good intentions: a look back at the PANTHER-IPF trial.
Michelle KamJulien CaliezHilario NunesThomas GillePublished in: Breathe (Sheffield, England) (2022)
The PANTHER-IPF trial was a turning point in treatment of idiopathic pulmonary fibrosis (#IPF) highlighting the importance of randomised controlled trials in determining treatment strategies, even for rare diseases and/or potentially fatal acute events https://bit.ly/3Oi0KwD.
Keyphrases
- idiopathic pulmonary fibrosis
- phase iii
- study protocol
- interstitial lung disease
- phase ii
- clinical trial
- liver failure
- respiratory failure
- randomized controlled trial
- open label
- drug induced
- intensive care unit
- aortic dissection
- combination therapy
- systemic sclerosis
- double blind
- acute respiratory distress syndrome